The effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG)

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective of this review is to assess the effect of P2Y12 receptor inhibitor therapy, administered within the recommended specific preoperative withdrawal period (five days for clopidogrel and ticagrelor, seven days for prasugrel) on in-hospital and 30-day all-cause mortality and perioperative bleeding in CABG patients.